Carbidopa/levodopa/melevodopaNeuroleptic malignant syndrome and elevation of procalcitonin levels: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2017年 / 1646卷 / 1期

关键词：

D O I：

10.1007/s40278-017-28445-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：81 / 81

相关论文

共 50 条

[1] Levodopa/carbidopa/quetiapineNeuroleptic malignant syndrome following drug withdrawal: case report
Reactions Weekly, 2021, 1849 (1) : 266 - 266
[2] Levodopa/carbidopa/entacaponeTakotsubo syndrome: case report
Reactions Weekly, 2015, 1555 (1) : 123 - 123
[3] Levodopa/carbidopa/pramipexoleOthello syndrome: case report
Reactions Weekly, 2012, 1383 (1) : 26 - 26
[4] Levodopa/Levodopa/carbidopa overdoseDopamine dysregulation syndrome: case report
Reactions Weekly, 2016, 1621 (1) : 158 - 158
[5] Carbidopa/levodopa/linezolid interactionSerotonin syndrome: case report
Reactions Weekly, 2016, 1590 (1) : 59 - 59
[6] Levodopa/carbidopa/ropiniroleDopamine dysregulation syndrome: case report
Reactions Weekly, 2018, 1713 (1) : 217 - 217
[7] Levodopa/carbidopa/pramipexoleOthello's syndrome: case report
Reactions Weekly, 2017, 1640 (1) : 226 - 226
[8] Levodopa/carbidopa abuseDopamine dysregulation syndrome: case report
Reactions Weekly, 2019, 1761 (1) : 231 - 231
[9] Entacapone/levodopa/carbidopa withdrawalNeuroleptic malignant-like syndrome in an elderly patient: case report
Reactions Weekly, 2011, 1364 (1) : 19 - 19
[10] Levodopa/carbidopa/parenteral nutrition supplements interactionNeuroleptic malignant-like syndrome: case report
Reactions Weekly, 2019, 1748 (1) : 294 - 294

← 1 2 3 4 5 →